Form 4 Filing for Donn Casale

Donn Casale, President of ARS Pharmaceuticals, Inc., was granted 898,456 stock options on July 1, 2026. These options have an exercise price of $7.96 and expire on June 30, 2036. The options vest over a period of time, with 25% vesting on June 1, 2027, and the remainder vesting monthly over the subsequent three years. This transaction is a grant of an option to acquire the company's common stock.